Boxer Capital’s 2seventy bio TSVT Stock Holding History

Boxer Capital’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-459,836	Closed	-$1.8M	–	69
2023 Q3	$1.8M	Hold	459,836	–	–	0.1%	58
2023 Q2	$4.65M	Hold	459,836	–	–	0.22%	56
2023 Q1	$4.69M	Hold	459,836	–	–	0.23%	52
2022 Q4	$4.31M	Hold	459,836	–	–	0.23%	51
2022 Q3	$6.69M	Hold	459,836	–	–	0.38%	45
2022 Q2	$6.07M	Hold	459,836	–	–	0.38%	49
2022 Q1	$7.84M	Buy	+459,836	New	+$7.8M	0.4%	46

Other funds holding TSVT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

ECM

Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Boxer Capital's TSVT Position: Q4 2023 in Review

Boxer Capital sold out of 2seventy bio (TSVT) in Q4 2023, closing a stake of 459,836 shares — an estimated $1.8M sold.

Boxer Capital first reported a position in TSVT in Q1 2022 and held it in 7 quarters. The position peaked at $7.84M in Q1 2022. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2023.

Boxer Capital reported no remaining 2seventy bio position as of Q4 2023 after selling out during the quarter.
Boxer Capital sold 459,836 2seventy bio shares in Q4 2023, an estimated $1.8M.
Boxer Capital first reported a position in 2seventy bio in Q1 2022 and held it in 7 quarters.
Boxer Capital's 2seventy bio position peaked at $7.84M in Q1 2022.
116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2023.

Based on Boxer Capital's 13F filing for Q4 2023, filed 14 Feb 2024.